CADL
Candel Therapeutics·NASDAQ
--
--(--)
--
--(--)
CADL Filings
Filing Date
Form Description
Form Type
2026-03-18
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-18 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-12
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2026-03-12 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2026-03-12
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-12 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-12
Form 8-K - Current report
Key Events
2026-03-12 · Key Events
Form 8-K - Current report
2026-02-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-23
Form 8-K - Current report
Key Events
2026-02-23 · Key Events
Form 8-K - Current report
2026-02-20
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-20 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-19
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-19 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-19
Form 8-K - Current report
Key Events
2026-02-19 · Key Events
Form 8-K - Current report
2026-01-28
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-28 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
